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Abstract
Background/Purpose. Management of the pancreatic remnant 
after distal pancreatectomy is still debated, the most serious 
complication is development of a pancreatic fi stula. We devel-
oped a nonclosure technique with saline-coupled bipolar 
electrocautery for preventing fi stula formation after distal 
pancreatectomy as an alternative to traditional stump closure 
methods.
Methods. The distinguishing feature of this technique is non-
closure of the stump, relying instead upon dependable ligation 
of the main pancreatic duct and sealing of the cut surface 
by shrinkage accomplished by low-temperature coagulation 
using saline-coupled bipolar electrocautery. A recent addition 
has been intraoperative stenting of the remnant pancreatic 
duct.
Results. To date we have used the nonclosure technique in 40 
cases, among which 5 (12.5%) developed fi stulas: 4 in the 
nonstenting subgroup (14.8%) and 1 in the stenting subgroup 
(7.7%). According to a recent classifi cation, 4 fi stulas were 
considered grade A; 1, grade B; and 0, grade C. The grade B 
patient did not undergo stenting.
Conclusion. Our preliminary experience should prompt more 
widespread evaluation of the nonclosure technique.
Key words Distal pancreatectomy · Pancreatic fi stula · Non-
closure technique · Saline-coupled bipolar electrocautery · 
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Introduction
Although advances in surgical technique have reduced 
the operative mortality rate of pancreatic resection to 
below 5% in high-volume centers,1–7 morbidity rates 
have changed little, ranging from 30% to 40%.2–4,6,7 
Pancreatic fi stula after distal pancreatectomy is a main 
cause of postoperative morbidity and is associated with 
numerous further complications, such as intraabdomi-
nal abscess, wound infection, sepsis, electrolyte imbal-
ance, malabsorption, and hemorrhage.8 Management 
of the pancreatic remnant after distal pancreatectomy 
remains a technical challenge. Several surgical resection 
and closure techniques have been introduced for man-
aging the pancreatic remnant so as to avoid pancreatic 
fi stulas; these include hand-sewn suture techniques, 
stapled closure techniques, or a combination of both,9–14 
as well as ultrasonic dissection devices,15 pancreaticoen-
teric anastomosis,16 application of meshes, seromuscu-
lar17 and gastric serosa patches,18 or sealing with fi brin 
glue.19,20 However, none of these techniques has been 
demonstrated to have a fi rm advantage over others as 
the optimal technique of pancreatic stump closure.8
We developed a new technique for preventing pan-
creatic fi stula after distal pancreatectomy. The distinc-
tive aspect of this technique involves treatment of the 
cut end of the pancreatic remnant. We employed a non-
closure technique as opposed to the previous closure 
techniques for managing the cut end of the pancreatic 
remnant. This technique has two main parts: reliable 
ligation of the main pancreatic duct, and the sealing 
of the cut surface by shrinkage induced by low-
temperature coagulation with saline-coupled bipolar 
electrocautery. Recently, intraoperative stenting of the 
remnant pancreatic duct has been added.
Surgical technique
Pancreatic transection and hemostasis
A vascular tape is looped under the transection line of 
the pancreas after ligation and division of the splenic 
artery and vein. The pancreatic body proximal to the 
transection plane is fastened by vascular tape, and the 
portion distal to the transection plane is ligated with 1-0 
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silk. A thin, narrow spatula is passed under the transec-
tion line to protect the underlying major vein, and the 
pancreas is transected sharply with a knife (Fig. 1). The 
vascular loop is loosened gradually, and hemostasis of 
the cut edge of the proximal pancreatic remnant is 
secured. Certain large arterial bleeding points are selec-
tively suture-ligated using 6-0 Maxon (Davis & Geck, 
St. Louis, MO, USA) without involving the pancreatic 
parenchyma (Fig. 2). Bleeding points from many smaller 
arteries and venous are coagulated carefully using 
saline-coupled bipolar electrocautery.
Sealing of the cut end of the pancreas with 
saline-coupled bipolar electrocautery
Ordinary bipolar electrocautery was modifi ed by addi-
tion of an infusion line to carry saline droplets down the 
inner surface of one arm of the forceps through an 
opening about 1.5 cm proximal to its tip, as described 
by Yamamoto et al. in 1999.21 This device was devel-
oped for hemostatic sealing and coagulation during 
hepatic parenchymal transection. Part of its effi cacy is 
related to collagen shrinkage and fusion, which can 
completely obliterate the lumens of small vessels and 
ducts. A regular drip infusion line is connected to the 
inner infusion line, and the rate of saline infusion can 
be adjusted easily using a fl exible clamp.
We usually use an electrosurgical generator setting of 
50 W and a saline drip rate of 0.3 ml/s; when the blades 
of the forceps are approximated to 1–2 mm, saline drop-
lets are directed to the tip of the forceps where they 
bubble immediately from heat. The saline facilitates 
continuous contact with tissue and dispersion of thermal 
energy, allowing tissue coagulation at a shallower depth 
than with standard electrical coagulation, while protect-
ing against carbonization and eschar formation by pro-
viding heat-coagulative surface cooling and by limiting 
the temperature to 100 °C. The pancreatic cut surface 
is sealed at a relatively low temperature, obliterating 
numerous small cut branches of the pancreatic duct in 
the cut end together with shrinkage of the pancreatic 
parenchyma by low-temperature coagulation (Fig. 3).
Fig. 1. Transection of the pancreas. The pancreatic body 
proximal to the transection plane is fastened by vascular tape, 
and the body distal to the transection plane is ligated with 1-0 
silk. A thin, narrow spatula is passed under the transection 
line to protect the underlying major vein, and the pancreas is 
transected sharply with a knife
Fig. 2. Arresting arterial bleeding from the cut surface of the pancreas (A). Large arterial bleeding points are selectively suture-
ligated using 6-0 Maxon (B) without involving the pancreatic parenchyma (arrow)
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Placement of the pancreatic stenting tube
A fi ne stenting tube, usually a radiopaque 3 or 4 Fr. 
polyethylene tube with multiple side holes every 3 cm, 
is inserted into the main pancreatic duct from the cut 
edge of the pancreatic remnant (Fig. 4). This tube is 
advanced to a location in the duodenum more than 5 cm 
beyond the papilla of Vater, as radiographically con-
fi rmed. The tube is expelled spontaneously after oral 
Fig. 3. Sealing of the cut surface of the pancreas with saline-
coupled bipolar electrocautery and setting of the pancreatic 
stenting tube. When the pancreatic cut surface is sealed at low 
temperature with heated bubbled saline using saline-coupled 
bipolar electrocautery, numerous small pancreatic ducts at the 
cut surface are sealed together with the shrinkage of pancre-
atic parenchyma by low-temperature coagulation without car-
bonization. The surface of the remnant becomes pale and fi rm 
(A, pre-; B, post-). Arrow, main pancreatic duct
intake is resumed. This tube provides drainage of pan-
creatic juice to the duodenum via the papilla of Vater 
and serves to decompress the main pancreatic duct.
Ligation of the main pancreatic duct
After insertion of the stenting tube, the main pancreatic 
duct of the cut surface is anchored by two stay sutures 
(6-0 Maxon) and traction to protrude the duct about 
1
Fig. 4. Placement of the pancreatic stenting tube. A thin 
stenting tube, usually 3 or 4 Fr. polyethylene tube with multi-
ple side holes every 3 cm, is inserted in the main pancreatic 
duct from the cut edge of the pancreatic remnant (right). 
The tube is passed into the duodenum more than 5 cm from 
the papilla of Vater, as confi rmed radiographically (left; 
arrowheads)
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3 mm from the cut surface, permitting ligation (Fig. 
5A). To allow the main pancreatic duct to extend 
beyond the cut edge, periductal pancreatic parenchyma 
should be removed carefully. For this maneuver, we 
usually use a delicate and thin instrument such as the 
tip of an ordinary monopolar electrocautery electrode 
(without electricity). Traction is upon the cut end of the 
main pancreatic duct with the stay sutures, and the duct 
is ligated with 5-0 Prolene (Ethicon, Hamburg, Germany; 
Fig. 5B). These manipulations are aided by surgical 
loupes at 2.5× magnifi cation. Closure of the cut end of 
the pancreatic parenchyma is not performed.
Drainage
Two drainage tubes, one in the splenic fossa (left sub-
phrenic space) and the other in close proximity to the 
pancreatic transection line, are positioned during the 
operation. The former is a closed-suction drain (J-VAC 
silicone drain, 19 Fr., round type; Johnson & Johnson, 
Somerville, NJ, USA); the later is a dual-lumen tube 
(Argyle Salem sump tube, 18 Fr.; Tyco Healthcare, 
Mansfi eld, MA, USA) covered with a silicone fi lm drain 
and suctioned continuously at low pressure (−10 to 
−15 cm H2O).
Diagnosis of pancreatic leakage
For precise diagnosis of pancreatic fi stula, the suction-
drainage sump tube is kept near the pancreatic cut 
end for 2 weeks. Exudate volume and amylase content 
are measured on alternate days. We defi ned a pancre-
atic fi stula as secretion of 30 ml or more of amylase-
rich drainage fl uid (>5000 units) per day for more than 
10 days, or need for interventional draining of a 
collection of amylase-rich fl uid.22 Pancreatic fi stulas 
were graded according to a recent international 
defi nition.23
Perioperative and postoperative pain management 
included epidural anesthesia or patient-controlled anal-
gesia in all patients.
Results
At present, this technique has been used in a total of 
40 cases of pancreatic cancer or tumors of the endo-
crine pancreas. The fi rst 27 operations did not use a 
stenting tube, while the subsequent 13 did. Pancreatic 
fi stulas developed in 5 cases overall (12.5%), with 4 
in the unstented subgroup (14.8%) and 1 in the 
stented group (7.7%). According to the recent fi stula 
defi nition, 4 fi stulas were classifi ed as grade A, 1 as 
grade B, and none as grade C. The grade B case was 
unstented.
Discussion
Mayo fi rst suggested the possibility of resection of the 
distal pancreas in 1913,24 but 44 years passed before 
Hannon and Sprafka25 reported the fi rst successful distal 
pancreatic resection. Management of the pancreatic 
remnant following distal pancreatectomy remains an 
important clinical problem. In particular, pancreatic 
fi stula has resisted prevention by several technical mod-
ifi cations that failed to signifi cantly reduce incidence.14 
Despite various methods of surgical resection and 
closure techniques employed in managing the proximal 
pancreas at distal resection, the fi stula rate has been 
between 8% and 39%.14,15,20
A recent multivariate analysis concerning pancreatic 
leakage after left pancreatectomy including clinicopath-
ological and operative factors26 indicated that the only 
variable found to signifi cantly affect likelihood of pan-
creatic leakage was whether the pancreatic duct was 
identifi ed and ligated at the time of pancreatectomy. 
Various closure techniques did not affect occurrence. 
Indeed, failure to ligate the pancreatic duct was associ-
ated with a fi vefold increase in risk of leakage compared 
with duct ligation.9 However, even if the pancreatic duct 
is ligated, pancreatic leakage will occur in 9.6% of cases 
and clinically important leakage will occur in 5.5%.
We previously adopted various closure techniques for 
the cut end of the pancreatic remnant, such as a hand-
sewn suture technique or a stapled closure technique. 
We sometimes encountered pancreatic fi stula, with 
high-viscosity, brownish discharge via the drainage tube 
placed near the closed cut end of the pancreatic paren-
chyma. All pancreatic fi stulas were cured by drainage, 
but hospital stays were prolonged. We hypothesized 
that pancreatic leakage after duct ligation could result 
from two factors. One is friability of the ligated portion 
of the duct caused by reduction of blood supply. Blood 
supply at the cut end of the pancreas has been found to 
be an important factor for reducing pancreatic fi stula 
after pancreaticoduodenectomy.27 For distal pancre-
atectomy, the local blood supply at the cut end of the 
duct is particularly important for ensuring viability of 
the ligated portion of the pancreatic duct. Some closure 
techniques will reduce blood supply to the cut end of 
the pancreatic remnant by compression from strings or 
staples. Another factor in fi stula formation is secretion 
from numerous small branches of the pancreatic duct at 
the cut end that no longer communicate with the main 
pancreatic duct.26,28 For focal areas of pancreatic paren-
chyma near the cut surface, the ducts may be inter-
rupted before they can drain into the main pancreatic 
duct. Closure techniques cannot completely seal these 
small branches, leading to persistent extravasation of 
enzyme-rich pancreatic fl uid that bathes the ligated duct 
and leads to subsequent duct disruption and leakage.29
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Fig. 5. Protrusion and ligation of the main pancreatic duct. 
After insertion of the stenting tube, two stay sutures are 
placed in the main pancreatic duct at the cut surface (6-0 
Maxon; white arrowhead, A). Traction is applied to protrude 
the duct about 3 mm from the cut surface, to facilitate ligation. 
For protrusion of the main pancreatic duct beyond the cut 
edge, periductal pancreatic parenchyma should be removed 
carefully. For this maneuver, we usually use a delicate, thin 
instrument like the tip of an ordinary monopolar electrocau-
tery electrode (arrow, A). No electricity is delivered (A). 
Traction is placed upon the cut end of the main pancreatic 
duct with the stay sutures, and the duct is ligated with 5-0 
Prolene (B)
Fig. 6. Histology of the pancreatic stump treated by saline-
coupled bipolar electrocautery and by the ordinary monopo-
lar electrocautery. Heat-induced degeneration penetrates to 
approximately 300 μm from the cut end after saline-coupled 
bipolar electrocautery (A), as compared with 800 μm from the 
cut end for ordinary monopolar electrocautery (B)
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Beginning in 2002, we adopted the nonclosure tech-
nique, emphasizing ligation of the main pancreatic duct 
and coagulation of the cut surface of the pancreatic 
remnant in a manner that can seal small pancreatic duct 
branches. Avoiding compression of the parenchyma, 
this method should not affect the blood supply at the 
cut end. For consistently reliable ligation, the duct liga-
tion is performed at the inner portion about 3 mm from 
the cut end, avoiding heat penetration. We believe that 
the blood supply of the pancreatic duct should be better 
at the inner portion than near the cut end, enhancing 
viability of the ligated portion.
The numerous small branches of the pancreatic duct 
of the cut surface are sealed along with local shrinkage 
of pancreatic parenchyma from heat-coagulative surface 
cooling and limitation of temperature to 100 °C, avoid-
ing carbonization and eschar formation. Because the 
pancreatic parenchyma contains abundant protein, 
shrinkage is induced at a low temperature. Heat-induced 
tissue injury from saline-coupled bipolar electrocautery 
penetrates only to a depth of 300 μm from the cut end 
according to histopathological examination (Fig. 6A), 
representing a shallower extent than with ordinary 
monopolar electrocautery (Fig. 6B). Areas obstructed 
by sealing most likely develop focal necrotizing pancre-
atitis, and mucinous brown necrotic discharge some-
times is drained. However, this focal pancreatitis largely 
abates within a week, and the discharge decreases and 
ceases rather than progressing to pancreatic fi stula.
For preventing the failure of the ligated portion of 
the pancreatic duct at the cut end, physiological internal 
pressure of the duct must be maintained. The two 
possible means accomplishing this include promoting 
the smooth fl ow of pancreatic juice without resistance 
through the papilla of Vater into the duodenum and 
reducing secretion of pancreatic juice. Beginning in 
1985, the endoscopic transpapillary stent placement in 
the pancreatic duct has been reported to be an effective 
technique for managing pancreatic pseudocyst or 
pancreatic duct disruption, and to prevent post-retro-
grade cholangiopancreatography (post-ERCP) pancre-
atitis.30–36 Although pancreatic stents have received 
widespread acceptance and application, few data are 
available concerning their use in perioperative drainage 
after distal pancreatectomy.37,38 The stenting tube acts 
to maintain physiological internal pressure across lesions 
or distal to them. These results led us to add intraopera-
tive placement of the pancreatic stenting tube to protect 
the ligated portion of the pancreatic duct at the cut end 
after distal pancreatectomy. Stenting should maintain 
the increased pressure in the pancreatic duct that accom-
panies contraction of the sphincter of Oddi. In our non-
closure technique, we inserted a narrow stenting tube 
from the cut edge of the pancreatic remnant across the 
major papilla. This tube extends into the duodenum for 
more than 5 cm beyond the papilla of Vater. With no 
stay suture, the tube is expelled naturally by peristalsis 
within 10 days postoperatively (data not shown).
For relaxation of the sphincter muscle of the papilla 
of Vater, a pasting agent including nitrous acid is used 
from the day of operation to the 7th postoperative 
day.39–41 In our series, the pancreatic fi stula rate was 
12.5% overall, 14.8% in the nonstenting group, and 
7.7% in the stenting group. For precise diagnosis of the 
pancreatic fi stula, we periodically collected fl uid from 
the pancreatic cut end via the suction drain for 2 weeks. 
This method is very sensitive in diagnosis of fi stulas 
compared to methods in some previous reports. Even 
so, our fi stula rate was much lower than with closure 
techniques such as hand-sewn suture (50.0%) or stapled 
methods (26.3%) previously used at our institution.
Our preliminary experience indicates that more wide-
spread evaluation of the nonclosure technique is indi-
cated, particularly by randomized, controlled comparison 
with other methods. Our department currently is pre-
paring for such a trial.
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